Iridian Asset Management LLC CT Acquires 483,635 Shares of Herbalife Ltd. (NYSE:HLF)

Iridian Asset Management LLC CT grew its holdings in shares of Herbalife Ltd. (NYSE:HLF - Free Report) by 49.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,468,636 shares of the company's stock after purchasing an additional 483,635 shares during the quarter. Herbalife makes up about 4.1% of Iridian Asset Management LLC CT's portfolio, making the stock its 5th biggest holding. Iridian Asset Management LLC CT owned approximately 1.48% of Herbalife worth $22,411,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HLF. Nomura Asset Management Co. Ltd. boosted its position in shares of Herbalife by 150.0% during the 1st quarter. Nomura Asset Management Co. Ltd. now owns 1,900 shares of the company's stock valued at $31,000 after acquiring an additional 1,140 shares during the last quarter. Lazard Asset Management LLC acquired a new position in shares of Herbalife during the 3rd quarter valued at about $66,000. Ameritas Investment Partners Inc. boosted its position in shares of Herbalife by 9.9% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 8,166 shares of the company's stock valued at $108,000 after acquiring an additional 736 shares during the last quarter. Point72 Middle East FZE acquired a new position in shares of Herbalife during the 4th quarter valued at about $121,000. Finally, Advisor Group Holdings Inc. boosted its position in shares of Herbalife by 50.0% during the 1st quarter. Advisor Group Holdings Inc. now owns 4,243 shares of the company's stock valued at $128,000 after acquiring an additional 1,415 shares during the last quarter.

Herbalife Trading Down 2.8 %

NYSE HLF traded down $0.24 during trading hours on Wednesday, reaching $8.61. The company had a trading volume of 3,224,055 shares, compared to its average volume of 2,273,343. The stock has a 50-day moving average of $9.39 and a 200 day moving average of $12.15. Herbalife Ltd. has a 1-year low of $6.68 and a 1-year high of $19.48. The stock has a market capitalization of $858.69 million, a P/E ratio of 6.06 and a beta of 1.22.

Herbalife (NYSE:HLF - Get Free Report) last issued its quarterly earnings results on Wednesday, February 14th. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.38 by ($0.10). The business had revenue of $1.20 billion for the quarter, compared to analysts' expectations of $1.19 billion. Herbalife had a negative return on equity of 19.56% and a net margin of 2.81%. The firm's revenue for the quarter was up .0% on a year-over-year basis. During the same quarter last year, the company earned $0.53 earnings per share. As a group, sell-side analysts predict that Herbalife Ltd. will post 1.8 EPS for the current year.

Analysts Set New Price Targets

HLF has been the topic of several recent research reports. Bank of America lowered their price target on shares of Herbalife from $10.00 to $8.00 and set an "underperform" rating on the stock in a research report on Thursday, March 21st. StockNews.com raised shares of Herbalife from a "hold" rating to a "buy" rating in a research report on Friday, February 16th. Mizuho decreased their target price on shares of Herbalife from $12.00 to $10.00 and set a "neutral" rating on the stock in a research report on Thursday, March 21st. Finally, DA Davidson decreased their target price on shares of Herbalife from $11.00 to $9.50 and set a "neutral" rating on the stock in a research report on Monday, March 25th. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $10.50.

Insiders Place Their Bets

In other Herbalife news, EVP Henry C. Wang purchased 2,778 shares of the business's stock in a transaction on Tuesday, March 26th. The shares were bought at an average cost of $9.30 per share, for a total transaction of $25,835.40. Following the completion of the purchase, the executive vice president now directly owns 176,194 shares of the company's stock, valued at $1,638,604.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, Director Juan Miguel Mendoza bought 16,079 shares of the business's stock in a transaction that occurred on Tuesday, March 26th. The shares were purchased at an average cost of $9.40 per share, for a total transaction of $151,142.60. Following the completion of the purchase, the director now owns 54,622 shares of the company's stock, valued at $513,446.80. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Henry C. Wang bought 2,778 shares of the business's stock in a transaction that occurred on Tuesday, March 26th. The shares were purchased at an average price of $9.30 per share, for a total transaction of $25,835.40. Following the completion of the purchase, the executive vice president now directly owns 176,194 shares of the company's stock, valued at approximately $1,638,604.20. The disclosure for this purchase can be found here. Insiders have acquired 85,757 shares of company stock worth $723,278 over the last three months. Company insiders own 0.94% of the company's stock.

Herbalife Company Profile

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.